Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01294566
What this trial is testing

FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers

Who this might be right for
Gastroparesis
GlaxoSmithKline 17
Early research (Phase 1)Study completedNCT00730431
What this trial is testing

Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 48
Not applicableStudy completedNCT02612766
What this trial is testing

Safety and Tolerability of Oat Containing Gluten-free Diet

Who this might be right for
Celiac Disease
Alfred Rusescu Institute for Mother and Child Care 25
Testing effectiveness (Phase 2)Ended earlyNCT02764229
What this trial is testing

Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Lycera Corp. 112
Early research (Phase 1)Study completedNCT00669825
What this trial is testing

Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal

Who this might be right for
Celiac Disease
Alvine Pharmaceuticals Inc. 36
Testing effectiveness (Phase 2)Study completedNCT01899703
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus

Who this might be right for
Cholestasis, Intrahepatic
GlaxoSmithKline 22
Early research (Phase 1)Study completedNCT01347190
What this trial is testing

Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
CSL Behring 25
Early research (Phase 1)Ended earlyNCT00976508
What this trial is testing

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

Who this might be right for
Colorectal NeoplasmsLung NeoplasmsBreast Neoplasms+2 more
Pfizer 24
Testing effectiveness (Phase 2)Study completedNCT00820079
What this trial is testing

ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)

Who this might be right for
Gastroesophageal Reflux
Addex Pharma S.A. 120
Testing effectiveness (Phase 2)Study completedNCT02981602
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection

Who this might be right for
Hepatitis BChronic Hepatitis B Atypical
GlaxoSmithKline 31
Early research (Phase 1)Study completedNCT04691232
What this trial is testing

Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis

Who this might be right for
Ulcerative ColitisAutoimmune Diseases
University of Erlangen-Nürnberg Medical School 11
Testing effectiveness (Phase 2)WithdrawnNCT01252108
What this trial is testing

Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers

Who this might be right for
Helicobacter Pylori Infection
Sequella, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT01150890
What this trial is testing

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Amgen 130
Very early researchNot Yet RecruitingNCT07420010
What this trial is testing

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

Who this might be right for
Ovarian CancerMesotheliomaColon Cancer
Weijia Fang, MD 24
Early research (Phase 1)Study completedNCT01582035
What this trial is testing

Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir

Who this might be right for
Hepatitis C
Janssen R&D Ireland 7
Testing effectiveness (Phase 2)Study completedNCT00953589
What this trial is testing

480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C, Chronic
Biolex Therapeutics, Inc. 74
Testing effectiveness (Phase 2)Study completedNCT02693652
What this trial is testing

Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine

Who this might be right for
Hepatitis B, Chronic
Aribio Lab Co., Ltd. 53
Early research (Phase 1)UnknownNCT05315180
What this trial is testing

A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors

Who this might be right for
Malignant NeoplasmsMetastatic Cancer
Betta Pharmaceuticals Co., Ltd. 80
Post-approval studies (Phase 4)Study completedNCT01337791
What this trial is testing

Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels

Who this might be right for
Chronic Hepatitis BPregnancy ComplicationsHigh Viral Load+1 more
Southeast University, China 88
Large-scale testing (Phase 3)Study completedNCT01567735
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 107
Next Page